| Date Filed | Type | Description |
| 03/28/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 03/15/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 02/22/2023 |
8-K
| Other Events Interactive Data |
| 02/14/2023 |
SC 13G
| Mint Tower Capital Management B.V. reports a 20.1% stake in Good Works II Acquisition Corporation |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/30/2023 |
SC 13G/A
| Weiss Asset Management LP reports a 0% stake in Good Works II Acquisition Corp. |
| 01/27/2023 |
SC 13G/A
| Magnetar Financial LLC reports a 0% stake in – Exit Filing)* Good Works II Acquisition Corp. |
| 01/25/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/25/2023 |
SC 13G/A
| HIGHBRIDGE CAPITAL MANAGEMENT LLC reports a 0% stake in Good Works II Acquisition Corp. |
| 01/20/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 12/29/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/25/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/13/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/13/2022 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submiss...|
Docs:
|
"DIRECT BIOLOGICS, INC., DB MERGER SUB, INC., DB DRE LLC, and DIRECT BIOLOGICS, LLC",
"Amendment to Amended and Restated Certificate of Incorporation of Good Works II Acquisition Corp.",
"Amended and Restated Business Combination Marketing Agreement",
"Good Works II Acquisition Corp. and Direct Biologics, LLC Announce a Definitive Agreement for a Business Combination HOUSTON and AUSTIN, Texas – Good Works II Acquisition Corp. , a publicly traded special purpose acquisition company , and Direct Biologics, LLC , a late-stage biotechnology company, today announced the signing of a definitive agreement that, upon the satisfaction of all closing conditions, will result in Direct Biologics becoming a publicly traded company. Upon transaction close, which is expected to occur in the first half of 2023, the combined company will be named Direct Biologics, Inc. and shares of its common stock are expected to trade on the Nasdaq Capital Market. Cary Grossman, Chief Executive Officer of Good Works II, commented, “We formed Good Works II with the obj...",
"INVESTOR PRESENTATION" |
|
| 09/27/2022 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 09/08/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 08/23/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 07/27/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
8-K
| Quarterly results |
| 05/23/2022 |
8-K
| Quarterly results |
| 05/03/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 03/03/2022 |
10-K/A
| Annual Report for the period ended December 31, 2021 [amend] |
| 02/17/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 02/14/2022 |
SC 13G
| PERISCOPE CAPITAL INC. reports a 7.2% stake in Good Works II Acquisition Corp |
| 02/14/2022 |
SC 13G
| Walleye Capital LLC reports a 5.5% stake in Good Works II Acquisition Corp. |
| 02/11/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/11/2022 |
SC 13G
| Shaolin Capital Management LLC reports a 6.7% stake in Good Works II Acquisition Corp. |
| 02/09/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/15/2021 |
4
| ZEIDMAN FRED S (Director) has filed a Form 4 on Good Works II Acquisition Corp.|
Txns:
| Gifted 250,000 shares
@ $0 |
|
| 11/15/2021 |
4
| GROSSMAN CARY M (President and CFO) has filed a Form 4 on Good Works II Acquisition Corp.|
Txns:
| Gifted 250,000 shares
@ $0 |
|
| 11/15/2021 |
4
| Wurth Douglas Clark (CEO) has filed a Form 4 on Good Works II Acquisition Corp.|
Txns:
| Gifted 250,000 shares
@ $0 |
|
|